Restricted accessResearch articleFirst published online 2010-2
Efficiency of Hyaloglide® in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II: a randomized,controlled,multicentre clinical trial
Hyaloglide® is a hyaluronan-based gel based on a novel auto-crosslinked technology designed to reduce postsurgical adhesions. Its efficacy was assessed in a multicentred randomized controlled trial comparing the results of flexor tenolysis in zone 2 following failed flexor tendon repairs. In the control group a standard release was performed. In the treated group, Hyaloglide® was applied into the flexor sheath and around the site of tenolysis. Forty-five patients, 19 controls and 26 treated with Hyaloglide®, were enrolled in 13 centres. All the patients were evaluated at 30, 60, 90 and 180 days after surgery by testing Total Active Motion, Quick-DASH questionnaire and number of working days lost after surgery. Patients in the Hyaloglide® group had a statistically better recovery of finger motion at all time intervals and returned earlier to work and daily activities. The use of Hyaloglide® did not appear to increase the complication rate.
Get full access to this article
View all access options for this article.
References
1.
AbatangeloGWeigelPH. New frontiers in medical sciences: redefining hyaluronan. Amsterdam, Elsevier Science BV, Excerpta Medica International Congress Series, 2000: 1196.
2.
AcunzoGGuidaMPellicanoM. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum Reprod. 2003, 18: 1918–21.
3.
AtzeiACalcagniMBredaB. Clinical evaluation of hyaluronan-based gel following microsurgical reconstruction of peripheral nerves of the hand. Microsurgery. 2007, 27: 2–7.
4.
BrunelliGLonginottiCBertazzoC. Adhesion reduction after knee surgery in a rabbit model by Hyaloglide, a hyaluronan derivative gel. J Orthop Res. 2005, 23: 1377–82.
Dam-HieuPLacroixCSaidG. Reduction of postoperative perineural adhesions by Hyaloglide gel: an experimental study in the rat sciatic nerve. Neurosurgery. 2005, 56: 425–33.
7.
DubertTFavalliP. Optimization of flexor tenolysis using a suture. Tech Hand Up Extrem Surg. 2005, 9: 211–14.
8.
EggliSDietscheAEggliS. Tenolysis after combined digital injuries in zone II. Ann Plast Surg. 2005, 55: 266–71.
9.
ElliotD. Primary flexor tendon repair – operative repair, pulley management and rehabilitation. J Hand Surg Br. 2002, 27: 507–13.
10.
FergusonRERinkerB. The use of a hydrogel sealant on flexor tendon repairs to prevent adhesion formation. Ann Plast Surg. 2006, 56: 54–8.
11.
GolashAKayAWarnerJG. Efficacy of ADCON-T/N after primary flexor tendon repair in Zone II: a controlled clinical trial. J Hand Surg Br. 2003, 28: 113–15.
12.
GomelVUrmanBGurganT. Pathophysiology of adhesion formation and strategies for prevention. J Reprod Med. 1996, 41: 35–41.
13.
HagbergL. Exogenous hyaluronate as an adjunct in the prevention of adhesions after flexor tendon surgery: a controlled clinical trial. J Hand Surg Am. 1992, 17: 132–6.
14.
HagbergLHeinegårdDOhlssonK. The contents of macromolecule solutes in flexor tendon sheath fluid and their relation to synovial fluid. A quantitative analysis. J Hand Surg Br. 1992, 17: 167–71.
15.
HagbergLTengbladAGerdinB. Hyaluronic acid in flexor tendon sheath fluid after sheath reconstructions in rabbits. A comparison between tendon sheath transplantation and conventional two stage procedures. Scand J Plast Reconstr Surg Hand Surg. 1991, 25: 103–7.
16.
HunterJMSchneiderLHMackinEJ. Tendon and nerve surgery in the hand. A third decade. Mosby, Year-Book, 1997.
17.
IşikSOztürkSGürsesS. Prevention of restrictive adhesions in primary tendon repair by HA-membrane: experimental research in chickens. Br J Plast Surg. 1999, 52: 373–9.
18.
JaibajiM. Advances in the biology of zone II flexor tendon healing and adhesion formation. Ann Plast Surg. 2000, 45: 83–92.
19.
KulkarniMHarrisSBElliotD. The significance of extensor tendon tethering and dorsal joint capsule tightening after injury to the hand. J Hand Surg Br. 2006, 31: 52–60.
20.
LandiA. Conventional tendon grafting. In:Alain MasqueletCFerreira AcacioC (Eds.) Severe traumatic defects of the upper limb. FESSH Martin Dunitz, 2003: 183–225.
21.
LaurentTC. The chemistry, biology and medical applications of hyaluronan and its derivatives. London, Portland Press, Wenner-Gren International Series, 1998.
22.
LillySIMesserTM. Complications after treatment of flexor tendon injuries. J Am Acad Orthop Surg. 2006, 14: 387–96.
23.
MaisVBraccoGLLittaP. Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomized, multicenter study. Hum Reprod. 2006, 21: 1248–54.
MenderesAMolaFTayfurV. Prevention of peritendinous adhesions following flexor tendon injury with seprafilm. Ann Plast Surg. 2004, 53: 560–4.
26.
MensitieriMAmbrosioLNicolaisL. Viscoelastic properties modulation of a novel autocrosslinked hyaluronic acid polymer. J Mater Sci Mater Med. 1996, 7: 695–8.
27.
MomoseTAmadioPCSunYL. Surface modification of extrasynovial tendon by chemically modified hyaluronic acid coating. J Biomed Mater Res. 2002, 59: 219–24.
28.
Moro-okaTMiuraHMawatariT. Mixture of hyaluronic acid and phospholipid prevents adhesion formation on the injured flexor tendon in rabbits. J Orthop Res. 2000, 18: 835–40.
29.
PaduaRPaduaLCeccarelliE. Italian version of the disability of the arm, shoulder and hand (DASH) questionnaire. Cross-cultural adaptation and validation. J Hand Surg Br. 2003, 28: 179–86.
30.
PellicanoMBramanteSCirilloD. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril. 2003, 80: 441–4.
31.
RenierDBellatoPBelliniD. Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration. Biomaterials. 2005, 26: 5368–74.
SmitXvan NeckJWAfokeA. Reduction of neural adhesions by biodegradable autocrosslinked hyaluronic acid gel after injury of peripheral nerves: an experimental study. J Neurosurg. 2004, 101: 648–52.
34.
StricklandJW. Flexor tenolysis. Hand Clin. 1985, 1: 121–32.
35.
StricklandJW. Flexor tendon surgery. Part 1: Primary flexor repair. J Hand Surg Br. 1989a, 14: 261–72.
36.
StricklandJW. Flexor tendon surgery. Part 2: Free tendon grafts and tenolysis. J Hand Surg Br. 1989b, 14: 368–82.
37.
StricklandJW. The scientific basis for advances in flexor tendon surgery. J Hand Ther. 2005a, 18: 94–110.
38.
StricklandJW. Delayed treatment of flexor tendon injuries including grafting. Hand Clin. 2005b, 21: 219–43.
39.
StricklandJWGlogovacSV. Digital function following flexor tendon repair in Zone II: a comparison of immobilization and controlled passive motion techniques. J Hand Surg Am. 1980, 5: 537-43
40.
TangJB. Clinical outcomes associated with flexor tendon repair. Hand Clin. 2005, 21: 199–210.
41.
ThamSKIrelandDCRiccioM. Reverse radial artery fascial flap: a treatment for the chronically scarred median nerve in recurrent carpal tunnel syndrome. J Hand Surg Am. 1996, 21: 849–54.
42.
WiigMAbrahamssonSOLundborgG. Tendon repair-cellular activities in rabbit deep flexor tendons and surrounding synovial sheaths and the effects of hyaluronan: an experimental study in vivo and in vitro. J Hand Surg Am. 1997, 22: 818–25.
